Crowley John F
SEC CIK 1400973 · EDGAR
BoughtSold
Most active insiders at NTLA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LEONARD JOHN M | Pres, CEO, Dir | — | $1.44M |
| 2 | Cohen Fred E | Dir | $1.40M | — |
| 3 | Dulac Edward J III | EVP, CFO | — | $234.2K |
| 4 | BASTA JAMES | EVP, GC | — | $112.4K |
| 5 | Lebwohl David | EVP, Chief Medical Off | — | $109.6K |
| 6 | Dube Michael P | VP, CAO | — | $104.4K |
| 7 | Clark Eliana | EVP, Chief Technical Off | — | $96.0K |
| 8 | Schultes Birgit C | EVP, CSO | — | $78.9K |
| 9 | Bhanji Muna | Dir | — | — |
| 10 | Keresty Georgia | Dir | — | — |
Crowley John F made no open-market trades at NTLA in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-16 | 2023-06-14 | NTLA | Intellia Therapeutics, Inc. | Crowley John F | Dir | A - Grant | $0.00 | +4,425 | 11.7K | +61% | $0 |
| D | 2022-06-16 | 2022-06-14 | NTLA | Intellia Therapeutics, Inc. | Crowley John F | Dir | A - Grant | $0.00 | +5,197 | 7,291 | +248% | $0 |
| 2022-01-13 | 2022-01-12 | TRDA | Entrada Therapeutics, Inc. | Crowley John F | Dir | P - Purchase | $9.72 | +5,000 | 5,000 | New | +$48.6K | |
| D | 2021-10-13 | 2021-10-11 | NTLA | Intellia Therapeutics, Inc. | Crowley John F | Dir | S - Sale+OE | $119.55 | -2,500 | 2,094 | -54% | -$298.9K |
| D | 2021-10-13 | 2021-10-11 | NTLA | Intellia Therapeutics, Inc. | Crowley John F | Dir | M - OptEx | $18.83 | +2,500 | 4,594 | +119% | +$47.1K |
| DM | 2021-10-07 | 2021-10-05 | NTLA | Intellia Therapeutics, Inc. | Crowley John F | Dir | S - Sale+OE | $130.54 | -10.0K | 10.8K | -48% | -$1.31M |
| D | 2021-10-07 | 2021-10-05 | NTLA | Intellia Therapeutics, Inc. | Crowley John F | Dir | M - OptEx | $18.83 | +10.0K | 12.1K | +478% | +$188.3K |
Purchase Sale Sale after option exercise All abbreviations